Drug Shortage Report for APO-MYCOPHENOLATE
Report ID | 212965 |
Drug Identification Number | 02352567 |
Brand name | APO-MYCOPHENOLATE |
Common or Proper name | MYCOPHENOLATE |
Company Name | APOTEX INC |
Market Status | MARKETED |
Active Ingredient(s) | MYCOPHENOLATE MOFETIL |
Strength(s) | 500MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 50 BLS |
ATC code | L04AA |
ATC description | IMMUNOSUPPRESSANTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2023-12-05 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-01-19 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2024-01-19 | French | Compare |
v4 | 2024-01-19 | English | Compare |
v3 | 2023-12-08 | French | Compare |
v2 | 2023-12-08 | French | Compare |
v1 | 2023-12-08 | English | Compare |
Showing 1 to 5 of 5